2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC812
Submitter : Ms. Noelle Pacer Date & Time: 10/13/2005 10:10:56
Organization : Ms. Noelle Pacer
Category : Health Professional
Issue Areas/Comments
I believe that the FDA used correct judgment in keeping the "morning-after" pill as a prescription product.